On the HCPLive Ulcerative Colitis condition center page, resources on the topics of medical news and expert insight into colitis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on UC research, treatment, and drug development.
April 22nd 2024
Announced on April 18, the approval is based on the VISIBLE 2 trial and comes less than 7 months after the approval of SC vedolizumab in ulcerative colitis.
Researcher Sorts Through Sea of IBS Remedies
May 22nd 2013As irritable bowel syndrome (IBS) remains a complicated condition to treat with an etiology that's still unknown, it's difficult for physicians to find the best proven therapies among new remedies and the variety of pharmacological and nondrug options they have been trying for years.
Colonoscopy Prevents Crohn's Disease Post-Operative Endoscopic Recurrence
May 22nd 2013While it's already clinically understood that most patients with Crohn's disease suffer a recurrence following an intestinal resection, researchers have not evaluated the best strategy to prevent the disease from recurring.
Abdominal, Bowel Symptom Improvement From Linaclotide Meets FDA Standards for IBS-C
May 21st 2013Patients taking linaclotide experience clinically meaningful improvement in abdominal and bowel symptoms, which closely correlate with the US Food and Drug Administration's new criteria for irritable bowel syndrome with constipation (IBS-C).
Identifying Symptoms of Irritable Bowel Syndrome in Patients with Inflammatory Bowel Disease
May 15th 2013Patients who have IBD, even those who are in clinical remission, often exhibit symptoms consistent with IBS, which can complicate the assessment and management of IBD and lead to unnecessary interventions.
The Role of Stigma in Irritable Bowel Syndrome
April 21st 2013The stigma attached to chronic diseases such as IBS has been shown to negatively affect patients' self-image and sense of worth, leading to worse outcomes. Being aware of this and working to counteract the psychological effects of stigma can improve the patient-physician relationship and lead to better outcomes.
Stress, Estrogen Connect Co-Occurrence of Irritable Bowel Syndrome, Temporomandibular Disorders
As more than 60 percent of women with temporomandibular disorders (TMD) also exhibit abdominal pain consistent with irritable bowel syndrome (IBS) symptoms, two researchers in the neural and pain sciences department of the University of Maryland School of Dentistry, in Baltimore, have developed a model to better illustrate the two conditions' comorbidity.
Common Crohn's Disease Index Lumps in Irritable Bowel Syndrome Patients
Though the Crohn's disease activity index (CDAI) is commonly applied in large Crohn's disease clinical trials to distinguish symptoms resulting from inflammation, a study published online Feb. 21 in Alimentary Pharmacology and Therapeutics demonstrated the index does not differentiate between active Crohn's disease patients and patients with the non-inflammatory irritable bowel syndrome (IBS).